References

2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

10.1093/eurheartj/ehac244 · 2022 · External reference

Cardio-oncology services: rationale, organization, and implementation

10.1093/eurheartj/ehy453 · 2019 · External reference

Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study

10.1200/jco.2015.64.0409 · 2016 · External reference

A population-based study of cardiovascular disease mortality risk in US cancer patients

10.1093/eurheartj/ehz766 · 2019 · External reference

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

10.1093/eurheartj/ehab674 · 2022 · External reference

Shared risk factors in cardiovascular disease and cancer

10.1161/circulationaha.115.020406 · 2016 · External reference

The spectrum of epidemiology underlying sudden cardiac death

10.1161/circresaha.116.304521 · 2015 · External reference

Out-of-hospital cardiac arrest: current concepts

10.1016/s0140-6736(18)30472-0 · 2018 · External reference

Poorer survival after out-of-hospital cardiac arrest among cancer patients: a population-based register study

2023 · External reference

Cancer is not associated with higher short or long-term mortality after successful resuscitation from out-of-hospital cardiac arrest when adjusting for prognostic factors

2020 · External reference

Long-term survival of out-of-hospital cardiac arrest patients with malignancy

10.1016/j.ajem.2017.04.051 · 2017 · External reference

Comorbidity and survival in out-of-hospital cardiac arrest

10.1016/j.resuscitation.2018.10.006 · 2018 · External reference

Unresolved reference

2023 · External reference

Unresolved reference

2024 · External reference

Unresolved reference

2025 · External reference

Registers of the Swedish total population and their use in medical research

10.1007/s10654-016-0117-y · 2016 · External reference

Unresolved reference

2025 · External reference

Diagnostic accuracy in the Swedish national patient register: a review including diagnoses in the outpatient register

10.1007/s10654-025-01221-0 · 2025 · External reference

Unresolved reference

2021 · External reference

The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research

10.1007/s10654-019-00511-8 · 2019 · External reference

The Swedish cause of death register

10.1007/s10654-017-0316-1 · 2017 · External reference

The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research

10.1007/s10654-009-9350-y · 2009 · External reference

Directed acyclic graphs for clinical research: a tutorial

10.7602/jmis.2023.26.3.97 · 2023 · External reference

Adaptation of the charlson comorbidity index for register-based research in Sweden

10.2147/clep.s282475 · 2021 · External reference

Unresolved reference

2024 · External reference

Earnings and work loss after colon and rectal cancer: a Swedish nationwide matched cohort study

10.1016/j.eclinm.2024.102770 · 2024 · External reference

Unresolved reference

2023 · External reference

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

10.1016/s0140-6736(07)61602-x · 2007 · External reference

Cardiovascular disease burden in adult patients with cancer: an 11-year nationwide population-based cohort study

10.1016/j.ijcard.2020.04.080 · 2020 · External reference

Shared risk factors for cardiovascular disease and cancer: implications for preventive health and clinical care in oncology patients

2016 · External reference

Prevalence of cardiovascular disease in patients with potentially curable malignancies: a national registry dataset analysis

10.1016/j.jaccao.2022.03.004 · 2022 · External reference

How common is pre-existing cardiovascular disease in cancer patients: what do we know? Does it matter?

10.1016/j.jaccao.2022.05.001 · 2022 · External reference

Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort study

10.1182/blood.2024025362 · 2024 · External reference

Trousseau's syndrome: multiple definitions and multiple mechanisms

10.1182/blood-2006-10-053736 · 2007 · External reference

Epidemiology of cancer-related venous thromboembolism

10.1016/j.beha.2008.12.001 · 2009 · External reference

Sudden cardiac arrest in patients with cancer in the general population: insights from the Paris-SDEC registry

10.1136/heartjnl-2024-324137 · 2024 · External reference

Risk of coronary heart disease in patients with cancer: a nationwide follow-up study from Sweden

10.1016/j.ejca.2011.09.015 · 2012 · External reference

Cardiovascular disease risk among cancer survivors: the Atherosclerosis Risk In Communities (ARIC) study

10.1016/j.jacc.2022.04.042 · 2022 · External reference

Incident cardiovascular disease among adults with cancer: a population-based cohort study

10.1016/j.jaccao.2022.01.100 · 2022 · External reference

Out-of-hospital cardiac arrest event after cancer diagnosis: a Korean metropolitan cohort study

10.1186/s12885-025-13717-9 · 2025 · External reference

Fatal heart disease among cancer patients

10.1038/s41467-020-15639-5 · 2020 · External reference

Prevalence of osimertinib-induced cardiotoxicity in non-small cell lung cancer patients: a systematic review and meta-analysis

10.1016/j.lungcan.2025.108629 · 2025 · External reference

Cardiac toxicities in multiple myeloma: an updated and a deeper look into the effect of different medications and novel therapies

10.1038/s41408-023-00849-z · 2023 · External reference

Anthracycline cardiotoxicity in adult cancer patients: JACC: cardiooncology state-of-the-art review

10.1016/j.jaccao.2024.07.016 · 2024 · External reference

Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy

10.1161/circulationaha.114.013777 · 2015 · External reference

Cardiovascular disease after hematopoietic stem cell transplantation in adults: JACC: cardiooncology state-of-the-art review

10.1016/j.jaccao.2024.06.004 · 2024 · External reference

Lung cancer and cardiovascular disease: common pathophysiology and treatment-emergent toxicity

10.1016/j.jaccao.2025.05.003 · 2025 · External reference

Lung cancer as a cardiotoxic state: a review

10.1007/s12032-017-1012-4 · 2017 · External reference

Cardiovascular complications associated with contemporary lung cancer treatments

10.1007/s11864-021-00869-6 · 2021 · External reference

Risk factors and prevention of cancer and CVDs: a chicken and egg situation

10.3390/jcm14093083 · 2025 · External reference

Risk of cardiovascular mortality in patients with gastric cancer

2025 · External reference

Correlation between pancreatic cancer and metabolic syndrome: a systematic review and meta-analysis

10.3389/fendo.2023.1116582 · 2023 · External reference

The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues

10.1038/s41416-019-0510-x · 2019 · External reference

Cardiovascular events and venous thromboembolism after primary malignant or non-malignant brain tumour diagnosis: a population matched cohort study in Wales (United Kingdom)

10.1186/s12916-023-03153-6 · 2023 · External reference

The risk of heart disease-related death among anaplastic astrocytoma patients after chemotherapy: a SEER population-based analysis

2022 · External reference

Cancer and cardiovascular disease: shared risk factors, mechanisms, and clinical implications: JACC: cardiooncology state-of-the-art review

10.1016/j.jaccao.2025.07.001 · 2025 · External reference

Unresolved reference

External reference